☆ 4.6 Article

Soluble CD4 and low molecular weight CD4-mimetic compounds sensitize cells to be killed by anti-HIV cytotoxic immunoconjugates

JOURNAL OF VIROLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines

Cheyenne Chaplain et al.

Summary: CD4-mimetic compounds have the potential to block the entry of HIV-1 into host cells. By modifying the compound structure, it is possible to enhance its antiviral activity and sensitivity, opening up the possibility for the development of more potent drugs.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

添加到收藏夹

Article Cell Biology

Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity

Annemarie Laumaea et al.

Summary: The conformation of HIV-1 envelope (Env) determines the susceptibility of infected CD4(+) T cells to antibody-dependent cellular cytotoxicity (ADCC). The downregulation of CD4 on infected macrophages by Nef, Vpu, and Env has a lesser impact on Env conformation and ADCC sensitivity compared to CD4(+) T cells. However, treatment of infected macrophages with small CD4 mimetics exposes vulnerable CD4-induced Env epitopes and sensitizes them to ADCC.

CELL REPORTS (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

HIV-1 remission and possible cure in a woman after haplo-cord blood transplant

Jingmei Hsu et al.

Summary: A mixed-race woman with acute myeloid leukemia achieved remission and a possible cure for HIV-1 through a CCR5A32/A32 haplo-cord transplant. Follow-up showed consistent presence of CCR5A32/A32 cord blood cells and the loss of detectable HIV-1 reservoirs. This case demonstrates the potential of stem cell transplantation in achieving HIV-1 control and possible cure.

CELL (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity

Christopher J. Fritschi et al.

Summary: Binding of HIV-1 to host cell receptors CD4 and CCR5/CXCR4 causes conformational changes in the viral envelope protein, promoting virus entry. CD4-mimetic compounds (CD4mcs) are small molecules that induce inactivating conformational changes in the viral envelope, making it susceptible to neutralization and ADCC. Novel CD4mcs based on an indoline scaffold demonstrate increased potency and breadth against HIV-1 variants, making them potential candidates for antiviral therapy.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

添加到收藏夹

Article Virology

Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage

Marianne Boutin et al.

Summary: HIV-1 envelope glycoproteins (Envs) play a crucial role in viral entry and are a preferred target for small molecule inhibitors. Temsavir inhibits the interaction between the host cell receptor CD4 and Env by binding a specific region on the Env subunit gp120. Besides blocking viral entry, temsavir also stabilizes the closed conformation of Env. This study shows that temsavir affects the glycosylation, proteolytic processing, and overall conformation of Env, which in turn impacts the recognition of HIV-1-infected cells by broadly neutralizing antibodies and their ability to mediate antibody-dependent cellular cytotoxicity (ADCC).

VIRUSES-BASEL (2023)

添加到收藏夹

Article Virology

Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC

Shilei Ding et al.

Summary: The HIV-1 accessory proteins Nef and Vpu can decrease CD4 levels to protect infected cells from antibody-dependent cellular cytotoxicity (ADCC) and prevent exposure of vulnerable epitopes. Small-molecule CD4 mimetics (CD4mc) based on indane and piperidine scaffolds sensitize HIV-1-infected cells to ADCC by exposing CD4-induced (CD4i) epitopes. A new family of CD4mc derivatives based on the piperidine scaffold, targeting the conserved Asp(368) Env residue, showed improved activity against difficult-to-neutralize viruses and sensitized infected cells to ADCC. These molecules have potential as candidates for strategies aiming to eliminate HIV-1-infected cells.

VIRUSES-BASEL (2023)

添加到收藏夹

Article Immunology

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1

Grant Klug et al.

Summary: We are studying the effectiveness of different monoclonal antibodies (mAbs) in delivering cytotoxic immunoconjugates (CICs) to HIV-infected cells. CICs targeted to the gp41 domain of the envelope protein (Env) have shown the highest efficacy, especially in the presence of soluble CD4. Our findings indicate that the ability to deliver an effective CIC does not necessarily correlate with the ability to neutralize or mediate Ab-dependent cellular cytotoxicity. The most effective mAbs are those targeting the immunodominant helix-loop-helix region (ID-loop) of gp41.

VACCINES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120

Jonathan Richard et al.

Summary: While HIV-1-mediated CD4 downregulation protects infected cells from ADCC, shed gp120 binds to uninfected bystander CD4+ T cells, sensitizing them to ADCC mediated by HIV+ plasma and triggering a cytokine burst. Temsavir, an HIV-1 attachment inhibitor, not only prevents gp120-CD4 interaction and alters Env antigenicity, but also blocks the immunomodulatory activities of shed gp120. Temsavir protects uninfected bystander CD4+ cells from ADCC responses and cytokine burst by preventing gp120 interaction, reducing shedding, and altering antigenicity.

CELL CHEMICAL BIOLOGY (2023)

添加到收藏夹

Review Oncology

Antibody-drug conjugates: in search of partners of choice

Jesus Fuentes-Antras et al.

Summary: Antibody-drug conjugates (ADCs) have been approved as anticancer drugs for both solid and hematological malignancies, but only a few have shown survival improvements over standard treatment. The most promising partners for ADCs are those that have additive or synergistic effects on tumor cells without overlapping toxicities. Co-administration with antiangiogenic compounds, HER2-targeting drugs, DNA-damage response agents, and immune checkpoint inhibitors (ICIs) are active candidates. The next generation of ADCs, with tumor-specific targets, improved conjugation technologies, and novel linkers and payloads, brings hope for combinatorial approaches.

TRENDS IN CANCER (2023)

添加到收藏夹

Review Pathology

In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure

Janet D. Siliciano et al.

Summary: This article discusses the latest developments in understanding the composition and measurement of the HIV reservoir, as well as the dynamics and stability of the reservoir. It also explores strategies to cure HIV infection.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)

添加到收藏夹

Article Microbiology

HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys

Brian Moldt et al.

PLoS Pathogens (2022)

添加到收藏夹

Review Microbiology

Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies

Tram M. Ta et al.

Summary: Although combination antiretroviral therapy (cART) has efficiently suppressed HIV-1 replication to undetectable levels, lifelong medication is still required. The formation of latent reservoirs during acute infection is a major obstacle to achieving a functional HIV cure. Early initiation of cART can reduce the size of the reservoirs. In addition to memory CD4+ T cell subsets, monocytes and derivative macrophages or dendritic cells also contribute to persistent virus infection.

FRONTIERS IN MICROBIOLOGY (2022)

添加到收藏夹

Article Microbiology

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption

Denise C. Hsu et al.

Summary: The study showed that the combination therapy of TLR7 agonist and dual bnAbs in rhesus macaques delayed viral rebound after antiretroviral therapy interruption, aligning with prior findings.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics

Christopher J. Fritschi et al.

Summary: This study reports the design and synthesis of butyl chain derivatives at the 3-position of the indane ring of the lead CD4-mimetic compound BNM-III-170. Optimization efforts were guided by crystallographic and computational analysis of small-molecule ligands targeting the Phe43 cavity of gp120, leading to the discovery of more potent CD4-mimetic compounds with a novel hydrogen bonding interaction between His105 and the butyl side chain. Further optimization of this interaction shows promise for the development of even more potent CD4-mimetic compounds.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Review Immunology

SMAC Mimetics as Therapeutic Agents in HIV Infection

Bengisu Molyer et al.

Summary: SMAC mimetics are being explored as a potential approach to eliminate HIV-infected cells, with the ability to reverse HIV latency and/or kill persistently infected cells. Their research and development could play a crucial role in future HIV cure strategies.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation

Claudia A. Jette et al.

Summary: The HIV-1 virus, which causes AIDS, impacts millions of people worldwide. Entry of the virus into target cells is mediated by the interaction of the HIV-1 envelope glycoprotein with the host receptor CD4, triggering conformational changes that allow fusion with the host cell membrane. Small molecule or peptide drugs that mimic CD4's interaction with the virus have been shown to induce similar structural changes in the virus envelope proteins.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Microbiology

Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir

Jyothi K. Rajashekar et al.

Summary: Research has shown that CD4mc can sensitize HIV-1-infected cells to ADCC by facilitating antibody recognition of epitopes on the viral envelope that are otherwise occluded. Combining CD4mc with specific antibodies can reduce viral replication and reservoir size by enhancing ADCC. The dependence on NK cells and Fc effector functions for these effects highlights the importance of ADCC in combating HIV-1.

CELL HOST & MICROBE (2021)

添加到收藏夹

Review Virology

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models

Katherine M. Bricker et al.

Summary: The "shock and kill" strategy for treating HIV-1 involves reactivating latent infected cells with LRAs, exposing them to immune system killing. Progress has been made in this area through the NHP model, which has both advantages and limitations for evaluating treatment efficacy.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Immunology

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity

Seth H. Pincus et al.

Summary: Research has shown that bispecific immunoadhesins binding to HIV envelope glycoproteins exhibit potent neutralization activity and deliver cytotoxic effects.

VACCINES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Curing HIV: Seeking to Target and Clear Persistent Infection

David M. Margolis et al.

CELL (2020)

添加到收藏夹

Review Immunology

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission

Jesper Damsgaard Gunst et al.

CURRENT OPINION IN HIV AND AIDS (2020)

添加到收藏夹

Article Virology

SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIVCCH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques

Amir Dashti et al.

JOURNAL OF VIROLOGY (2020)

添加到收藏夹

Review Immunology

Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors

Annemarie Laumaea et al.

CURRENT OPINION IN HIV AND AIDS (2020)

添加到收藏夹

Article Microbiology

Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation

Katherine M. Bricker et al.

PLOS PATHOGENS (2020)

添加到收藏夹

Article Virology

A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity

Shilei Ding et al.

JOURNAL OF VIROLOGY (2019)

添加到收藏夹

Article Chemistry, Applied

Development of an Effective Scalable Enantioselective Synthesis of the HIV-1 Entry Inhibitor BNM-III-170 as the Bis-trifluoroacetate Salt

Junhua Chen et al.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)

添加到收藏夹

Article Chemistry, Medicinal

Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir

Nicholas A. Meanwell et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Article Virology

eCD4-Ig Variants That More Potently Neutralize HIV-1

Ina Fetzer et al.

JOURNAL OF VIROLOGY (2018)

添加到收藏夹

Correction Multidisciplinary Sciences

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys (vol 563, pg 360, 2018)

Erica N. Borducchi et al.

NATURE (2018)

添加到收藏夹

Article Virology

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160

Seth H. Pincus et al.

JOURNAL OF VIROLOGY (2017)

添加到收藏夹

Article Virology

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins

Seth H. Pincus et al.

JOURNAL OF VIROLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4+ T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity

Jonathan Richard et al.

EBIOMEDICINE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

CD4 mimetics sensitize HIV-1-infected cells to ADCC

Jonathan Richard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein

Jia Chen et al.

SCIENCE (2015)

添加到收藏夹

Article Virology

Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains

Weizao Chen et al.

JOURNAL OF VIROLOGY (2014)

添加到收藏夹

Article Microbiology

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

Julian H. Elliott et al.

PLOS PATHOGENS (2014)

添加到收藏夹

Article Microbiology

Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART

Paul W. Denton et al.

PLOS PATHOGENS (2014)

添加到收藏夹

Article Microbiology

Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing

Datsen George Wei et al.

PLOS PATHOGENS (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Jean-Philippe Julien et al.

SCIENCE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

Dmitry Lyumkis et al.

SCIENCE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication

Ekaterina Dadachova et al.

PLOS ONE (2012)

添加到收藏夹

Article Hematology

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Kristina Allers et al.

BLOOD (2011)

添加到收藏夹

Article Virology

An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum

Guido Ferrari et al.

JOURNAL OF VIROLOGY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Broad neutralization coverage of HIV by multiple highly potent antibodies

Laura M. Walker et al.

NATURE (2011)

添加到收藏夹

Editorial Material Microbiology

Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs

Edward A. Berger et al.

PLOS PATHOGENS (2010)

添加到收藏夹

Article Medicine, General & Internal

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins

Ekaterina Dadachova et al.

PLOS MEDICINE (2006)

添加到收藏夹

Article Immunology

Molecular characterization, reactivation, and depletion of latent HIV

DG Brooks et al.

IMMUNITY (2003)

添加到收藏夹

Article Immunology

In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection

SH Pincus et al.

JOURNAL OF IMMUNOLOGY (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis

L McHugh et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

添加到收藏夹

Article Immunology

Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: Phase 1/2 study

WT Shearer et al.

JOURNAL OF INFECTIOUS DISEASES (2000)

添加到收藏夹

Article Immunology

Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice

H Goldstein et al.

JOURNAL OF INFECTIOUS DISEASES (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.